CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...
Le Lézard22m
Dolby Laboratories Reports First Quarter 2025 Financial Results
Dolby Laboratories, Inc. today announced the company's financial results for the first quarter of fiscal 2025. "We are off to ...
nzcity.co.nz33m
Fake papers are contaminating the world’s scientific literature, fueling a corrupt industry and slowing legitimate lifesaving medical research
But now, fraudsters have infiltrated the academic publishing industry to prioritize profits over scholarship. Equipped with ...